InvestorsHub Logo
Followers 8
Posts 1379
Boards Moderated 0
Alias Born 03/27/2013

Re: None

Tuesday, 08/05/2014 11:27:26 PM

Tuesday, August 05, 2014 11:27:26 PM

Post# of 425976
IMO, should the FDA not reinstate the SPA or take some other conciliatory action with Amarin, then the company must rise up and act to overcome further delays. This becomes a fight for life and Amarin must authorize their Sales Force to provide information to Docs based on Clinical Trials and other peer reviewed evaluations. It's the proverbial "straw" and it must trigger the start of the 1st Amendment battle. If the Amarin Sales Force provides honest 3rd party information about the benefits of EPA, the Courts have ruled that it is allowable free speech. If the FDA wants to fight Amarin on this, then I say let them go for it....let's see how that plays out in the Media, the Congress and the Courts.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News